These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22736318)

  • 1. Generalised lymphadenopathy as the first manifestation of lupus nephritis.
    Al-Hashimi H; Bhowmik A
    BMJ Case Rep; 2010 Apr; 2010():. PubMed ID: 22736318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sterile empyematous pleural effusion in a patient with systemic lupus erythematosus: a diagnostic challenge.
    Kriegel MA; Van Beek C; Mostaghimi A; Kyttaris VC
    Lupus; 2009 Jun; 18(7):581-5. PubMed ID: 19433457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis.
    Choi CB; Won S; Bae SC
    Lupus; 2018 May; 27(6):1007-1011. PubMed ID: 29448881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A young girl with chronic isolated cervical lymphadenopathy found to have lupus lymphadenopathy, progressing to develop lupus nephritis: a case report.
    Jayawickreme KP; Subasinghe S; Weerasinghe S; Perera L; Dissanayaka P
    J Med Case Rep; 2021 Jun; 15(1):328. PubMed ID: 34176492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis.
    F L; Y T; X P; L W; H W; Z S; H Z; Z H;
    Lupus; 2008 Jul; 17(7):622-9. PubMed ID: 18625634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group.
    Chan TM; Li FK; Tang CS; Wong RW; Fang GX; Ji YL; Lau CS; Wong AK; Tong MK; Chan KW; Lai KN
    N Engl J Med; 2000 Oct; 343(16):1156-62. PubMed ID: 11036121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case with good response to belimumab for lupus nephritis complicated by IgG4-related disease.
    Yamamoto M; Aochi S; Suzuki C; Nakamura S; Murakami R; Ogawa Y; Takahashi H
    Lupus; 2019 May; 28(6):786-789. PubMed ID: 30917769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Manifestation of diffuse proliferative lupus nephritis in a patient treated with long-term mycophenolate mofetil].
    Sixdorf U; Bauer H; Märker-Hermann E
    Dtsch Med Wochenschr; 2006 Oct; 131(41):2266-9. PubMed ID: 17036267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary lymphangioleimyomatosis and systemic lupus erythematosus in a menopausal woman.
    Hong H; Yang R; Li X; Wang M; Ma Z
    BMC Nephrol; 2018 Apr; 19(1):90. PubMed ID: 29669532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of lupus nephritis--a work in progress.
    Falk RJ
    N Engl J Med; 2000 Oct; 343(16):1182-3. PubMed ID: 11036127
    [No Abstract]   [Full Text] [Related]  

  • 11. The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus.
    Weng MY; Weng CT; Liu MF
    Clin Rheumatol; 2010 Jul; 29(7):771-5. PubMed ID: 20195879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a multitarget therapy with prednisolone, mycophenolate mofetil, and tacrolimus in a patient with type B insulin resistance syndrome complicated by lupus nephritis.
    Temmoku J; Asano T; Saito K; Matsumoto H; Fujita Y; Furuya-Yashiro M; Matsuoka N; Oda A; Tanabe H; Sato S; Shio-Yano K; Sasajima T; Kiko Y; Kobayashi H; Watanabe H; Shimabukuro M; Migita K
    Mod Rheumatol Case Rep; 2022 Jan; 6(1):41-46. PubMed ID: 34651654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephritis as an initial diagnosis of lupus in Nigerian patients.
    Adelowo OO; Umeizudike T; Olaosebikan H; Awobusuyi JO
    Afr J Med Med Sci; 2014 Jun; 43(2):99-105. PubMed ID: 25474984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil for remission induction in severe lupus nephritis.
    Cross J; Dwomoa A; Andrews P; Burns A; Gordon C; Main J; Mathieson P; O'Donoghue D; Jayne D;
    Nephron Clin Pract; 2005; 100(3):c92-100. PubMed ID: 15824513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic lupus erythematosus as the concomitant manifestation of angioimmunoblastic T-cell lymphoma.
    Suzuki A; Shoji N; Aoki N; Asazuma N; Machinami R; Kojima M; Okai T
    Mod Rheumatol; 2017 Mar; 27(2):360-363. PubMed ID: 25401231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methimazole-induced bullous systemic lupus erythematosus: a case report.
    Seo JY; Byun HJ; Cho KH; Lee EB
    J Korean Med Sci; 2012 Jul; 27(7):818-21. PubMed ID: 22787382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current management of lupus nephritis.
    Houssiau FA; Lauwerys BR
    Best Pract Res Clin Rheumatol; 2013 Jun; 27(3):319-28. PubMed ID: 24238689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of minimal change disease treated successfully with mycophenolate mofetil in a patient with systemic lupus erythematosus.
    Hong YH; Yun DY; Jung YW; Oh MJ; Kim HJ; Lee CK
    Korean J Intern Med; 2011 Dec; 26(4):470-3. PubMed ID: 22205851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late recurrence of lupus nephritis in a renal transplant recipient: response to mycophenolate mofetil.
    Ahuja TS; Boughton J; Weiss V; Memon A; Remmers A; Rajaraman S
    Am J Med Sci; 2001 Sep; 322(3):166-9. PubMed ID: 11570784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological therapy of lupus nephritis.
    Fine DM
    JAMA; 2005 Jun; 293(24):3053-60. PubMed ID: 15972568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.